| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/17/2005 | CN1654040A Novel medical uses of perennial sowthistle and preparing method for intermediate thereof |
| 08/17/2005 | CN1215076C Heteroaromatic inhibitors of fructose 1, 6-bisphosphatase |
| 08/17/2005 | CN1215071C Erigeron ester B and its preparation method as well as application in pharmacy |
| 08/17/2005 | CN1215069C Sulfonamicles and derivatives thereof that moulate the activity of endothelin |
| 08/17/2005 | CN1215067C 哒嗪酮醛糖还原酶抑制剂 Pyridazinone aldose reductase inhibitors |
| 08/17/2005 | CN1215060C Condensed pyrazole compound, composition containing it and its application |
| 08/17/2005 | CN1215059C Novel heterocyclic compounds and salts thereof and medicinal use of same |
| 08/17/2005 | CN1214817C Coupling factor 6 inhibitor and potentiator and use thereof |
| 08/17/2005 | CN1214811C Traditional Chinese medicine for treating neurosism, extracting process, formation process and use thereof |
| 08/17/2005 | CN1214797C Medicine for treating piles |
| 08/17/2005 | CN1214794C Use of prostaglandin A1 in treatment of nerve degenerative diseases such as cerebral ischemia apoplexy |
| 08/17/2005 | CN1214790C Method for preparing isoxazole substituted composition for treating inflammation |
| 08/17/2005 | CN1214788C Compositions for treatment and prevention of cardiovascular diseases |
| 08/16/2005 | US6930220 Adhering therapeutic tool |
| 08/16/2005 | US6930207 derivatives which inhibit pancreatic lipase and therefore can be used in combating or preventing obesity and hyperlipaemias |
| 08/16/2005 | US6930123 Benz(f)indole compounds useful for Inflammatory Diseases |
| 08/16/2005 | US6930120 Oxazolyl-arylproplonic acid derivatives and their use as ppar agonists |
| 08/16/2005 | US6930118 3-Oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
| 08/16/2005 | US6930111 Substituted heterocyclic compounds |
| 08/16/2005 | US6930108 Nitrogen compounds such as 2-[2-ethoxy-5-(4-ethyl-piperazine-1-sulphonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one, used for prophylaxis of psoriasis, diabetes, alopecia, genetic, sexual, cardiovascular or genetic disorders |
| 08/16/2005 | US6930101 Thiazolopyrimidines useful as TNFα inhibitors |
| 08/16/2005 | US6930100 Phosphate prodrugs of fluoroxindoles |
| 08/16/2005 | US6930096 Administering to a subject before the onset of an ischemic episode at daily dosages of 1-2 g of free cdp-choline |
| 08/16/2005 | US6930085 G-type peptides to ameliorate atherosclerosis |
| 08/16/2005 | US6929798 Compositions and methods for treatment of microbial infections |
| 08/16/2005 | CA2342974C Methods and compositions for inhibition of angiogenesis |
| 08/16/2005 | CA2094859C Anticonvulsant fructopyranose cyclic sulfites and sulfates |
| 08/11/2005 | WO2005073236A2 Thieno-imino acid derivatives for use as matrix metalloproteinase inhibitors |
| 08/11/2005 | WO2005073218A1 Therapeutic agent for vasospasm accompanying bypass operation |
| 08/11/2005 | WO2005049058A8 Radix salviae miltiorrhizae, extract and composition thereof for the treatment of the aspirin resistance diseases |
| 08/11/2005 | WO2005023188A3 Compounds and methods |
| 08/11/2005 | WO2004014847A8 Mcp-1 receptor antagonists and method of use thereof |
| 08/11/2005 | US20050176964 Nicotinamide derivatives useful as p38 inhibitors |
| 08/11/2005 | US20050176927 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; diagnosis |
| 08/11/2005 | US20050176828 Polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; antiproliferative agents; inhibition of cellular polyamine synthesis, even in the presence of exogenously supplied spermidine to inhibit cell growth and proliferation |
| 08/11/2005 | US20050176821 Meta-substituted phenylene sulphonamide derivatives |
| 08/11/2005 | US20050176820 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 08/11/2005 | US20050176817 Anticancer agents; prevention of infections; autoimmune diseases;antiarthritic agents; cystic fibrosis |
| 08/11/2005 | US20050176816 Controlling infections; antiallergens; antiarthritic agents; cardiovascular disorders |
| 08/11/2005 | US20050176815 Malaria therapy |
| 08/11/2005 | US20050176813 Modulating the potassium ion channel activity of T-cells; autoimmune and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis or transplant rejection; synthesis by reaction of an acetophenone such as khellinone with an aryl aldehyde |
| 08/11/2005 | US20050176808 Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof |
| 08/11/2005 | US20050176806 Use of 1-[3-hydroxy-1-adamantylamino]acetyl-2-cyano-pyrrolidine, for example with other anticholesterol drugs such as statins |
| 08/11/2005 | US20050176802 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/11/2005 | US20050176800 Preterm labor, dysmenorrhea, asthma, hypertension, fertility disorder, sexual dysfunction, undesired blood clotting, bone disorders, preeclampsia or eclampsia, or an eosinophil disorder; use with phosphodiesterase inhibitors; e.g. 7-[(2R,3R)-3-Chloro-1-(4-hydroxynonyl)-pyrrolidin-2-yl]-hept-5-enoic acid |
| 08/11/2005 | US20050176799 drugs such as 1-Benzyl-3-(2-furyl)-5-trifluoromethylpyrazole, capable of modulating biosynthesis of cyclic guanosine monophosphate, used for therapy and prophylaxis of cardiovascular disorders such as hypertension, angina pectoris, cardiac insufficiency, thrombosis or atherosclerosis |
| 08/11/2005 | US20050176796 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 08/11/2005 | US20050176791 5-HT2B receptor antagonists |
| 08/11/2005 | US20050176780 2,5-disubstituted 3-mercaptopentanoic acid |
| 08/11/2005 | US20050176770 Novel 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 08/11/2005 | US20050176766 2,3-Oxidosqualene-lanosterol cyclase inhibitors |
| 08/11/2005 | US20050176765 For therapy of glaucoma, dementia such as Alzheimer's disease and vascular dementia, depression, attention deficit disorder, sleep disorder, schizophrenia, pain, ischemia; -[1-[1-(3-Thienoyl)piperidin-4-yl]piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one |
| 08/11/2005 | US20050176762 Tachykinin receptor subtypes NK3 and NK2 (NK neurokinin); various diseases including respiratory system disorders, autoimmune disorders, psychological disorders, skin disorders |
| 08/11/2005 | US20050176760 and tumors; imino-, thiocarbonyl- or hydroxyimino-substituted N-heterocyclic amide compounds such as 2-(3-aminomethylphenylamino)-N-[3-chloro-4-(2-hydroxyiminopyrrolidin-1-yl)phenyl]-2-phenylacetamide |
| 08/11/2005 | US20050176756 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted |
| 08/11/2005 | US20050176747 hypertension and asthma; vasorelaxants |
| 08/11/2005 | US20050176723 (Halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 08/11/2005 | US20050176722 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 08/11/2005 | US20050176720 Pharmaceutical composition for the treatment of CNS and other disorders |
| 08/11/2005 | US20050176714 Pyridazine derivatives |
| 08/11/2005 | US20050176712 Integrin expression inhibitor |
| 08/11/2005 | US20050176711 Phthalazine derivatives for treating inflammatory diseases |
| 08/11/2005 | US20050176709 Selective NPY (Y5) antagonists |
| 08/11/2005 | US20050176708 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 08/11/2005 | US20050176704 Hydroxymorpholinone derivative and medicinal use thereof |
| 08/11/2005 | US20050176700 (2-methoxyphenyl)acetic acid-7-{4-[3-(2-methoxybenzyloxy)-propoxy]phenyl}-3-(2-thiophen-2-ylacetyl)-3,9-diazabicyclo[3.3.1]non-6-en-6-yl-methyl ester; metabolically stable, orally bioavailable and sufficiently soluble; industrial scale; non-peptidic nature, low molecular weight |
| 08/11/2005 | US20050176698 Neuropeptide Y antagonists |
| 08/11/2005 | US20050176694 steroids such as (11 beta )-11-17-dihydroxy-21-[N-acetyl-S-(4-nitroxybutyroyl) cisteinyloxy]pregne-1,4-diene-3,20-dione having antiinflammatory, immunodepressive and angiostatic activity |
| 08/11/2005 | US20050176687 Use of tyrosine kinase inhibitors for treating autoimmune diseases |
| 08/11/2005 | US20050176673 guanin-9-yl, adenin-9-yl, 2,6-diaminopurin-9-yl, 2-aminopurin-9-yl or their 1-deaza, 3-deaza, or 8-aza compounds, or cytosin-1-yl - ethoxymethanephosphonic acid derivatives, used to treat osteoporosis and other disorders of bone metabolism, cancer, or viral infections |
| 08/11/2005 | US20050176659 Polypeptide contributing to regulating the metabolism of triglycerides; obesity as well as related disorders such as eating disorder, cachexia, diabetes mellitus, hypertension, coronary heart disease, hypercholesterolemia, dyslipidemia, osteoarthritis, gallstone, cancers of the reproductive organs |
| 08/11/2005 | US20050176639 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 08/11/2005 | US20050176123 Protease inhibitor |
| 08/11/2005 | US20050176060 Crystal structure |
| 08/11/2005 | US20050176013 Identifying modulators of 3'-phosphoadenosine 5'-phosphosulfate synthase 1(PAPPS-1) activity; antitumor agents; tumor diagnostics |
| 08/11/2005 | US20050175699 Multilamellar system for the administration of active agents by means of ingestion |
| 08/11/2005 | US20050175639 Methods |
| 08/11/2005 | US20050175580 Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines |
| 08/11/2005 | CA2555763A1 Therapeutic agent for vasospasm accompanying bypass operation |
| 08/11/2005 | CA2554735A1 Therapeutic and carrier molecules |
| 08/11/2005 | CA2554599A1 Novel brain natriuretic peptide variants and methods of use thereof |
| 08/11/2005 | CA2554185A1 Neuroprotective complex for treatment of cerebral ischemia and injury |
| 08/11/2005 | CA2553931A1 Erythrocyte function modifying substance |
| 08/11/2005 | CA2553084A1 Novel benzofuran derivative, medicinal composition containing the same, and uses of these |
| 08/11/2005 | CA2549029A1 Compositions for treatment or prevention of metabolic syndrome |
| 08/10/2005 | EP1561760A2 Low molecular weight heparin salt with thriethanolamine |
| 08/10/2005 | EP1561751A1 Fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals |
| 08/10/2005 | EP1561462A2 Anti arrhytmic composition and methods of treatment |
| 08/10/2005 | EP1561458A1 Rapidly disintegrable solid preparation |
| 08/10/2005 | EP1560837A2 Novel ampiphilic derivatives of alpha-c-phenyl n-tert-butyl nitrone |
| 08/10/2005 | EP1560828A1 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 08/10/2005 | EP1560826A1 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same |
| 08/10/2005 | EP1560816A1 Quinazoline derivatives |
| 08/10/2005 | EP1560812A1 Aminocyclohexyl ether compounds and uses thereof |
| 08/10/2005 | EP1560630A2 7h-dibenzo[b,g][1,5]dioxocin-5-one derivatives and use thereof |
| 08/10/2005 | EP1507514A4 Controlled release compositions of estradiol metabolites |
| 08/10/2005 | EP1451166B1 Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof |
| 08/10/2005 | EP1399406B1 Novel estrogen receptor ligands and methods i |
| 08/10/2005 | EP1392674B1 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors |
| 08/10/2005 | EP1345946B1 Macroheterocylic compounds useful as kinase inhibitors |